Alexander Philip Gamble, MD
Internal Medicine · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Office
- 1
- Since medical school
- 16 years
- Saint Louis University School of Medicine, 2010
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Looking this up.
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Gamble’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence C184081 · Current
Licensed to practise in California · since 2023 · expires 2027-04-30 · Saint Louis University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Hospice and Palliative Medicine
- American Board of Internal Medicine - Internal Medicine
- American Board of Psychiatry and Neurology - Psychiatry
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$55,097
Medicare paid this office $55,097 for 141 people. Most of that is long return visits and Botox.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 66 | $27,389 | $173 |
| New patient visit (60+ min) | 35 | $7,153 | $204 |
| Return visit (30+ min) | 24 | $5,037 | $126 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 25 | $4,761 | $111 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 24 | $3,554 | $148 |
See all 8 services
| Long return visit (40+ min) | 66 | $27,389 | $173 |
| New patient visit (60+ min) | 35 | $7,153 | $204 |
| Return visit (30+ min) | 24 | $5,037 | $126 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 25 | $4,761 | $111 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 24 | $3,554 | $148 |
| Short return visit (20+ min) | 18 | $1,836 | $83 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 14 | $1,619 | $74 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 14 | $963 | $46 |
Who their Medicare patients are
141 Original Medicare patients in 2024. Average age 72 · Under 65 17% · 85 and older 14% · Women 63% · Also on Medicaid 34% · Health risk score 3.18. Sicker patients than 9 in 10 peers; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 74% · Cancer 46% · Chronic kidney disease 38% · Coronary heart disease 36% · Depression 35% · Diabetes 34% · Heart failure 30% · Atrial fibrillation 29% · Dementia 26% · COPD 22% · Stroke 16%.
The office billed $279,586, Medicare allowed $70,848 and paid $55,097; for 385 services of 11 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 141 | 385 | 72 | 3.18 | $279,586 | $55,097 |
| 2023 | 81 | 150 | 73 | 2.58 | $104,186 | $18,419 |
| 2022 | 80 | 166 | 78 | 3.11 | $36,417 | $16,188 |
| 2021 | 189 | 272 | 77 | 2.79 | $71,850 | $33,328 |
| 2020 | 140 | 285 | 78 | 2.83 | $71,917 | $31,941 |
| 2019 | 128 | 524 | 78 | 3.00 | $118,400 | $44,235 |
| 2018 | 145 | 491 | 78 | 2.95 | $98,757 | $37,181 |
| 2017 | 159 | 412 | 66 | 2.57 | $82,960 | $29,055 |
| 2016 | 33 | 114 | 62 | 2.94 | $18,007 | $6,585 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 5 services
| New patient visit (60+ min) | 20 | $3,340 | $167 |
| Long return visit (40+ min) | 14 | $3,059 | $133 |
| New patient visit (60+ min) | 17 | $2,839 | $167 |
| Long return visit (40+ min) | 14 | $2,394 | $133 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 11 | $1,975 | $110 |
2022: 4 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 62 | $9,604 | $155 |
| Advance care planning, first 30 minutes | 33 | $2,411 | $60 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 16 | $1,949 | $78 |
| Advance care planning, each additional 30 minutes | 17 | $1,109 | $58 |
2021: 4 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 157 | $24,870 | $156 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 30 | $2,872 | $82 |
| Advance care planning, first 30 minutes | 42 | $2,863 | $62 |
| Advance care planning, each additional 30 minutes | 15 | $994 | $58 |
2020: 4 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 115 | $19,306 | $164 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 44 | $5,250 | $83 |
| Advance care planning, first 30 minutes | 34 | $2,312 | $62 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 16 | $1,132 | $57 |
2019: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 83 | $16,218 | $81 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 64 | $10,562 | $158 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 54 | $6,009 | $57 |
| Extended inpatient or observation hospital service, first hour | 41 | $4,227 | $72 |
| Advance care planning, first 30 minutes | 33 | $2,587 | $62 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 12 | $1,282 | $107 |
2018: 8 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 70 | $9,786 | $80 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 78 | $8,612 | $56 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 42 | $4,415 | $105 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 24 | $3,758 | $150 |
| Extended inpatient or observation hospital service, first hour | 23 | $1,835 | $71 |
| Advance care planning, first 30 minutes | 13 | $1,458 | $61 |
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 11 | $1,251 | $69 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 16 | $1,248 | $78 |
2017: 8 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 47 | $7,912 | $147 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 44 | $5,174 | $80 |
| Advance care planning, first 30 minutes | 50 | $3,400 | $59 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 35 | $2,382 | $29 |
| Advance care planning, each additional 30 minutes | 33 | $2,183 | $55 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 25 | $2,174 | $53 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 16 | $1,776 | $104 |
| Hospital discharge day management, 30 minutes or less | 15 | $987 | $55 |
2016: 3 services
| Advance care planning, each additional 30 minutes | 15 | $1,803 | $55 |
| Advance care planning, first 30 minutes | 18 | $1,167 | $58 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 11 | $848 | $29 |
Drugs they prescribed that Part D paid
$7,312
Pharmacies billed $7,312 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 56% of their Part D prescriptions (103 of 183) in 2024. A higher opioid share than 9 in 10 peers; the typical internal medicine clinician is at 1%. Long-acting opioids: 36% of their opioid prescriptions.
178 generic and fewer than 11 brand-name prescriptions · $7,312 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Buprenorphine | 13 | $2,152 | $166 |
| Oxycodone | 47 | $930 | $20 |
| Morphine Sulfate Er | 15 | $465 | $31 |
| Gabapentin | 12 | $191 | $16 |
| Hydrocodone-Acetaminophen | 13 | $117 | $9 |
See all 7 drugs
| Buprenorphine | 13 | $2,152 | $166 |
| Oxycodone | 47 | $930 | $20 |
| Morphine Sulfate Er | 15 | $465 | $31 |
| Gabapentin | 12 | $191 | $16 |
| Hydrocodone-Acetaminophen | 13 | $117 | $9 |
| Escitalopram | 13 | $107 | $8 |
| Sertraline | 12 | $14 | $1 |
Year by year
| 2024 | 183 | 54 | 56% (103) | None | $7,312 |
| 2023 | 39 | 19 | 39% (15) | None | $1,416 |
| 2017 | 50 | 21 | None | None | $4,211 |
| 2016 | 38 | 13 | None | None | $1,520 |
| 2015 | 174 | 19 | None | 13% | $10,174 |
| 2014 | 255 | 43 | None | None | $18,253 |
| 2013 | 789 | 57 | 0% (0) | 7% | $37,963 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2015: 1 drug
| Trazodone | 24 | $103 | $4 |
2014: 4 drugs
| Venlafaxine Hcl Er | 12 | $259 | $22 |
| Lisinopril | 18 | $154 | $9 |
| Atorvastatin | 12 | $150 | $13 |
| Trazodone | 23 | $111 | $5 |
2013: 21 drugs
| Clozapine | 40 | $6,836 | $171 |
| Divalproex Sodium Er | 18 | $3,009 | $167 |
| Ziprasidone | 23 | $2,426 | $105 |
| Escitalopram | 28 | $1,625 | $58 |
| Quetiapine | 46 | $1,558 | $34 |
| Bupropion Hcl Sr | 40 | $1,517 | $38 |
| Risperidone | 43 | $1,094 | $25 |
| Venlafaxine Hcl Er | 41 | $832 | $20 |
| Trazodone | 82 | $579 | $7 |
| Mirtazapine | 35 | $414 | $12 |
| Buspirone | 19 | $400 | $21 |
| Sertraline | 39 | $371 | $10 |
| Prazosin | 12 | $348 | $29 |
| Hydroxyzine Pamoate | 23 | $227 | $10 |
| Lithium Carbonate | 20 | $190 | $10 |
| Citalopram Hbr | 34 | $177 | $5 |
| Lorazepam | 19 | $141 | $7 |
| Benztropine Mesylate | 23 | $137 | $6 |
| Lamotrigine | 16 | $95 | $6 |
| Clonazepam | 17 | $70 | $4 |
| Fluoxetine | 12 | $68 | $6 |
Money from drug and device companies
$35 in 2023
| 2023 | 1 | 1 | None | $35 |
| 2021 | 1 | 1 | None | $17 |
| 2019 | 3 | 3 | None | $66 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbvie | Botox | $35 | 1 payment
|
See the published payment
| Abbvie | Meals · 2023-09-02 | Botox | $35 |
See earlier years (2021, 2019)
2021: $17
| Incyte | Pemazyre | $17 | 1 payment
|
2019: $66
| DePuy Synthes Sales | Vivigen | $42 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Calquence | $12 | 1 payment
|
| Genzyme | Libtayo | $11 | 1 payment
|
Professional record
- NPI
- 1528389681
- Licence
- CA C184081, MO 2015015501California C184081: Current · expires 2027-04-30
- Trained
- Saint Louis University School of Medicine, 2010 · 16 years ago
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RH0002X (207RH0002X); Internal medicine (207R00000X); Psychiatry (2084P0800X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2010-06-11
- NPI last updated
- 2023-07-05
- NPI record certified
- 2023-07-05
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 2700 Clay Edwards Dr Ste 240, North Kansas City, MO, 64116